Skip to content

Evaluation of intralesional triamcinolone in the management of cheilitis granulomatosa by Facescan

Evaluation of intralesional triamcinolone in the management of cheilitis granulomatosa by Facescan

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008262
Enrollment
Unknown
Registered
2016-04-11
Start date
2016-04-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cheilitis granulomatosa

Interventions

injection and dental treatment:Intralesional triamcinolone and dental treatment
dental treatment:dental treatment

Sponsors

Department of Oral Medicine, Peking University School and Hospital of Stomatology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Clinical and pathological diagnosis of chelitis granulomatosa; 2. Individuals who agree to participate in this study; 3. Male and female who aged between 18 and 70 years old; 4. No mental disorders; 5. Ability of independent behavior and decision-making; 6. Without sarcoidosis, crohn's disease, tuberculosis.

Exclusion criteria

Exclusion criteria: 1) Individuals who don't agree to participate in this study; 2) Individuals who have taken Long-term corticosteroids for systemic disorderss; 3) Individuals who have taken Local or systemic corticosteroids during the last two weeks; 4) Individuals who have serious cardiovascular disease; 5) Individuals who have acute infectious patients.

Design outcomes

Primary

MeasureTime frame
3D data from Facescan;

Secondary

MeasureTime frame
Visual Analogue Scale;

Countries

China

Contacts

Public ContactLiu Yang

Peking University School and Hospital of Stomatology

shannon13579@163.com+86 13810849747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026